Recommended standards for fetal magnetocardiography

Barbara Grimm; Jens Haueisen; minna Huotilainen; Silke Lange; Peter van Leeuwen; Teresa Menendez; M.J. Peters; Ekkehard Schleussner; Uwe Schneider

doi:10.1046/j.1460-9592.2003.00330.x

Recommended standards for fetal magnetocardiography

Barbara Grimm, Jens Haueisen, minna Huotilainen, Silke Lange, Peter van Leeuwen, Teresa Menendez, M.J. Peters, Ekkehard Schleussner, Uwe Schneider

Research output: Contribution to journal › Article › Academic › peer-review

56 Citations (Scopus)

Abstract

Fetal magnetocardiography (FMCG) is increasingly being used in research and diagnostics of fetal heart function. Currently, FMCG is the only noninvasive procedure available, comparable to postnatal ECG, which can be used to assess cardiac electrophysiology during the second and third trimester of pregnancy. For a reliable evaluation and full clinical acceptance of this new technique, large numbers of patient investigations are required which can only be obtained in multicenter studies. An international standard protocol is needed to allow pooling of sufficient data and to permit the comparison of studies performed in different centers. This article provides recommended standards for FMCG in the fields of data acquisition and data analysis. (PACE 2003; 26:2121–2126)

Original language	Undefined
Pages (from-to)	2121-2126
Journal	Pacing and clinical electrophysiology
Volume	26(11)
Issue number	11
DOIs	https://doi.org/10.1046/j.1460-9592.2003.00330.x
Publication status	Published - 2003

Keywords

cardiac time intervals
Standards
heart rate variability
METIS-214870
IR-71909
Fetal magnetocardiography

Access to Document

10.1046/j.1460-9592.2003.00330.x

Cite this

@article{2425c6b3fcda4f62ba5a5f7b9e177638,

title = "Recommended standards for fetal magnetocardiography",

abstract = "Fetal magnetocardiography (FMCG) is increasingly being used in research and diagnostics of fetal heart function. Currently, FMCG is the only noninvasive procedure available, comparable to postnatal ECG, which can be used to assess cardiac electrophysiology during the second and third trimester of pregnancy. For a reliable evaluation and full clinical acceptance of this new technique, large numbers of patient investigations are required which can only be obtained in multicenter studies. An international standard protocol is needed to allow pooling of sufficient data and to permit the comparison of studies performed in different centers. This article provides recommended standards for FMCG in the fields of data acquisition and data analysis. (PACE 2003; 26:2121–2126)",

keywords = "cardiac time intervals, Standards, heart rate variability, METIS-214870, IR-71909, Fetal magnetocardiography",

author = "Barbara Grimm and Jens Haueisen and minna Huotilainen and Silke Lange and {van Leeuwen}, Peter and Teresa Menendez and M.J. Peters and Ekkehard Schleussner and Uwe Schneider",

year = "2003",

doi = "10.1046/j.1460-9592.2003.00330.x",

language = "Undefined",

volume = "26(11)",

pages = "2121--2126",

journal = "Pacing and clinical electrophysiology",

issn = "0147-8389",

publisher = "Wiley-Blackwell",

number = "11",

}

Recommended standards for fetal magnetocardiography. / Grimm, Barbara; Haueisen, Jens; Huotilainen, minna; Lange, Silke; van Leeuwen, Peter; Menendez, Teresa; Peters, M.J.; Schleussner, Ekkehard; Schneider, Uwe.

In: Pacing and clinical electrophysiology, Vol. 26(11), No. 11, 2003, p. 2121-2126.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Recommended standards for fetal magnetocardiography

AU - Grimm, Barbara

AU - Haueisen, Jens

AU - Huotilainen, minna

AU - Lange, Silke

AU - van Leeuwen, Peter

AU - Menendez, Teresa

AU - Peters, M.J.

AU - Schleussner, Ekkehard

AU - Schneider, Uwe

PY - 2003

Y1 - 2003

N2 - Fetal magnetocardiography (FMCG) is increasingly being used in research and diagnostics of fetal heart function. Currently, FMCG is the only noninvasive procedure available, comparable to postnatal ECG, which can be used to assess cardiac electrophysiology during the second and third trimester of pregnancy. For a reliable evaluation and full clinical acceptance of this new technique, large numbers of patient investigations are required which can only be obtained in multicenter studies. An international standard protocol is needed to allow pooling of sufficient data and to permit the comparison of studies performed in different centers. This article provides recommended standards for FMCG in the fields of data acquisition and data analysis. (PACE 2003; 26:2121–2126)

AB - Fetal magnetocardiography (FMCG) is increasingly being used in research and diagnostics of fetal heart function. Currently, FMCG is the only noninvasive procedure available, comparable to postnatal ECG, which can be used to assess cardiac electrophysiology during the second and third trimester of pregnancy. For a reliable evaluation and full clinical acceptance of this new technique, large numbers of patient investigations are required which can only be obtained in multicenter studies. An international standard protocol is needed to allow pooling of sufficient data and to permit the comparison of studies performed in different centers. This article provides recommended standards for FMCG in the fields of data acquisition and data analysis. (PACE 2003; 26:2121–2126)

KW - cardiac time intervals

KW - Standards

KW - heart rate variability

KW - METIS-214870

KW - IR-71909

KW - Fetal magnetocardiography

U2 - 10.1046/j.1460-9592.2003.00330.x

DO - 10.1046/j.1460-9592.2003.00330.x

M3 - Article

VL - 26(11)

SP - 2121

EP - 2126

JO - Pacing and clinical electrophysiology

JF - Pacing and clinical electrophysiology

SN - 0147-8389

IS - 11

ER -